{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:52:02Z","timestamp":1649181122607},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11886-016-0808-8","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T01:48:45Z","timestamp":1477878525000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies"],"prefix":"10.1007","volume":"18","author":[{"given":"Zainab","family":"Samad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"808_CR1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCULATIONAHA.108.795781","volume":"118","author":"LD Gillam","year":"2008","unstructured":"Gillam LD. Is it time to update the definition of functional mitral regurgitation?: structural changes in the mitral leaflets with left ventricular dysfunction. Circulation. 2008;118:797\u20139.","journal-title":"Circulation"},{"key":"808_CR2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jtcvs.2005.04.019","volume":"130","author":"KJ Grande-Allen","year":"2005","unstructured":"Grande-Allen KJ, Barber JE, Klatka KM, et al. Mitral valve stiffening in end-stage heart failure: evidence of an organic contribution to functional mitral regurgitation. J Thorac Cardiovasc Surg. 2005;130:783\u201390.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"808_CR3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2004.06.079","volume":"45","author":"KJ Grande-Allen","year":"2005","unstructured":"Grande-Allen KJ, Borowski AG, Troughton RW, et al. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. J Am Coll Cardiol. 2005;45:54\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","volume":"65","author":"AW Asgar","year":"2015","unstructured":"Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015;65:1231\u201348.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR5","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","volume":"63","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57\u2013185.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.110.009803","volume":"124","author":"RJ Bommel van","year":"2011","unstructured":"van Bommel RJ, Marsan NA, Delgado V, et al. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation. 2011;124:912\u20139.","journal-title":"Circulation"},{"key":"808_CR7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","volume":"42","author":"A Vahanian","year":"2012","unstructured":"Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1\u201344.","journal-title":"Eur J Cardiothorac Surg"},{"key":"808_CR8","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1410490","volume":"371","author":"PK Smith","year":"2014","unstructured":"Smith PK, Puskas JD, Ascheim DD, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371:2178\u201388. Important paper in ischemic MR.","journal-title":"N Engl J Med"},{"key":"808_CR9","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1161\/CIRCULATIONAHA.113.005223","volume":"129","author":"AW Castleberry","year":"2014","unstructured":"Castleberry AW, Williams JB, Daneshmand MA, et al. Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. Circulation. 2014;129:2547\u201356.","journal-title":"Circulation"},{"key":"808_CR10","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.jacc.2014.10.016","volume":"64","author":"PA Grayburn","year":"2014","unstructured":"Grayburn PA, Carabello B, Hung J, et al. Defining \u201csevere\u201d secondary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol. 2014;64:2792\u2013801. Important paper describing assessment of MR.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-9149(87)90376-6","volume":"60","author":"LW Stevenson","year":"1987","unstructured":"Stevenson LW, Bellil D, Grover-McKay M, et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1987;60:654\u20138.","journal-title":"Am J Cardiol"},{"key":"808_CR12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0002-9149(98)00623-7","volume":"82","author":"AB Levine","year":"1998","unstructured":"Levine AB, Muller C, Levine TB. Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling. Am J Cardiol. 1998;82:1299\u2013301. A10.","journal-title":"Am J Cardiol"},{"key":"808_CR13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(99)00059-4","volume":"83","author":"BD Lowes","year":"1999","unstructured":"Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol. 1999;83:1201\u20135.","journal-title":"Am J Cardiol"},{"key":"808_CR14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0002-8703(00)90036-X","volume":"139","author":"S Capomolla","year":"2000","unstructured":"Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J. 2000;139:596\u2013608.","journal-title":"Am Heart J"},{"key":"808_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/hrt.72.1.63","volume":"72","author":"B Seneviratne","year":"1994","unstructured":"Seneviratne B, Moore GA, West PD. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. Br Heart J. 1994;72:63\u20138.","journal-title":"Br Heart J"},{"key":"808_CR16","first-page":"207","volume":"9","author":"E Agricola","year":"2008","unstructured":"Agricola E, Oppizzi M, Pisani M, Meris A, Maisano F, Margonato A. Ischemic mitral regurgitation: mechanisms and echocardiographic classification. Eur J Echocardiogr. 2008;9:207\u201321.","journal-title":"Eur J Echocardiogr"},{"key":"808_CR17","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehv343","volume":"36","author":"Z Samad","year":"2015","unstructured":"Samad Z, Shaw LK, Phelan M, et al. Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. Eur Heart J. 2015;36:2733\u201341. Recent paper on management of FMR in a tertiary care center.","journal-title":"Eur Heart J"},{"key":"808_CR18","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147\u2013239.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurjhf\/hfp051","volume":"11","author":"E Agricola","year":"2009","unstructured":"Agricola E, Ielasi A, Oppizzi M, et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail. 2009;11:581\u20137.","journal-title":"Eur J Heart Fail"},{"key":"808_CR20","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/01.CIR.0000065226.24159.E9","volume":"107","author":"MG St John Sutton","year":"2003","unstructured":"St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985\u201390.","journal-title":"Circulation"},{"key":"808_CR21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/europace\/eur047","volume":"13","author":"L Biase Di","year":"2011","unstructured":"Di Biase L, Auricchio A, Mohanty P, et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace. 2011;13:829\u201338.","journal-title":"Europace"},{"key":"808_CR22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/eurheartj\/ehn063","volume":"29","author":"C Ypenburg","year":"2008","unstructured":"Ypenburg C, Lancellotti P, Tops LF, et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J. 2008;29:757\u201365.","journal-title":"Eur Heart J"},{"key":"808_CR23","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2004.07.036","volume":"44","author":"H Kanzaki","year":"2004","unstructured":"Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan 3rd J. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol. 2004;44:1619\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR24","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","volume":"103","author":"F Grigioni","year":"2001","unstructured":"Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759\u201364.","journal-title":"Circulation"},{"issue":"Suppl 1","key":"808_CR25","first-page":"II103","volume":"108","author":"BH Trichon","year":"2003","unstructured":"Trichon BH, Glower DD, Shaw LK, et al. Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. Circulation. 2003;108 Suppl 1:II103\u201310.","journal-title":"Circulation"},{"key":"808_CR26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9149(02)03301-5","volume":"91","author":"BH Trichon","year":"2003","unstructured":"Trichon BH, Felker GM, Shaw LK, Cabell CH, O\u2019Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91:538\u201343.","journal-title":"Am J Cardiol"},{"key":"808_CR27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jtcvs.2005.10.041","volume":"131","author":"JS Rankin","year":"2006","unstructured":"Rankin JS, Hammill BG, Ferguson Jr TB, et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg. 2006;131:547\u201357.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"808_CR28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0735-1097(00)01202-X","volume":"37","author":"FH Edwards","year":"2001","unstructured":"Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001;37:885\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR29","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.jacc.2007.02.043","volume":"49","author":"T Mihaljevic","year":"2007","unstructured":"Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49:2191\u2013201.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR30","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.112.143818","volume":"126","author":"KM Chan","year":"2012","unstructured":"Chan KM, Punjabi PP, Flather M, et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the randomized ischemic mitral evaluation (RIME) trial. Circulation. 2012;126:2502\u201310.","journal-title":"Circulation"},{"key":"808_CR31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jtcvs.2011.05.006","volume":"143","author":"PK Smith","year":"2012","unstructured":"Smith PK, Michler RE, Woo YJ, et al. Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg. 2012;143:111\u20137. 117 e1.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"808_CR32","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","volume":"374","author":"RE Michler","year":"2016","unstructured":"Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374:1932\u201341.","journal-title":"N Engl J Med"},{"key":"808_CR33","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1161\/CIRCULATIONAHA.111.072256","volume":"125","author":"MA Deja","year":"2012","unstructured":"Deja MA, Grayburn PA, Sun B, et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation. 2012;125:2639\u201348.","journal-title":"Circulation"},{"key":"808_CR34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1312808","volume":"370","author":"MA Acker","year":"2014","unstructured":"Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23\u201332.","journal-title":"N Engl J Med"},{"key":"808_CR35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","volume":"374","author":"D Goldstein","year":"2016","unstructured":"Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344\u201353.","journal-title":"N Engl J Med"},{"key":"808_CR36","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","volume":"97","author":"A Rossi","year":"2011","unstructured":"Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97:1675\u201380.","journal-title":"Heart"},{"key":"808_CR37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0022-5223(98)70282-X","volume":"115","author":"SF Bolling","year":"1998","unstructured":"Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998;115:381\u20136. discussion 387-8.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"808_CR38","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jtcvs.2006.02.062","volume":"132","author":"MA Acker","year":"2006","unstructured":"Acker MA, Bolling S, Shemin R, et al. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg. 2006;132:568\u201377. 577 e1-4.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"808_CR39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1010-7940(00)00345-6","volume":"17","author":"ES Bishay","year":"2000","unstructured":"Bishay ES, McCarthy PM, Cosgrove DM, et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 2000;17:213\u201321.","journal-title":"Eur J Cardiothorac Surg"},{"key":"808_CR40","doi-asserted-by":"crossref","unstructured":"Rogers JH, Bolling SF. What to do with functional mitral regurgitation: what do we really know and how can we find out? Eur J Cardiothorac Surg. 2012;42:915\u20137. Important opinion paper on MR.","DOI":"10.1093\/ejcts\/ezs472"},{"key":"808_CR41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2004.09.073","volume":"45","author":"AH Wu","year":"2005","unstructured":"Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"T Feldman","year":"2011","unstructured":"Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395\u2013406.","journal-title":"N Engl J Med"},{"key":"808_CR43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2013.04.030","volume":"62","author":"L Mauri","year":"2013","unstructured":"Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013;62:317\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR44","doi-asserted-by":"crossref","unstructured":"Velazquez EJ, Samad Z, Al-Khalidi HR, et al. The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. Am Heart J. 2015;170:1050\u20139. e3. Paper on mitraclip using a historical medically treated control cohort.","DOI":"10.1016\/j.ahj.2015.08.004"},{"key":"808_CR45","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2013.02.094","volume":"62","author":"F Maisano","year":"2013","unstructured":"Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62:1052\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjcard.2015.04.025","volume":"116","author":"F D\u2019Ascenzo","year":"2015","unstructured":"D\u2019Ascenzo F, Moretti C, Marra WG, et al. Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am J Cardiol. 2015;116:325\u201331.","journal-title":"Am J Cardiol"},{"key":"808_CR47","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jacc.2011.06.061","volume":"58","author":"A Auricchio","year":"2011","unstructured":"Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol. 2011;58:2183\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"808_CR48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCINTERVENTIONS.114.001607","volume":"7","author":"O Backer De","year":"2014","unstructured":"De Backer O, Piazza N, Banai S, et al. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circulation Cardiovasc Interv. 2014;7:400\u20139.","journal-title":"Circulation Cardiovasc Interv"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-016-0808-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-016-0808-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-016-0808-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T04:45:11Z","timestamp":1568522711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-016-0808-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s11886-016-0808-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]},"article-number":"128"}}